Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

A cationic nanoemulsion for the delivery of next-generation RNA vaccines.

Brito LA, Chan M, Shaw CA, Hekele A, Carsillo T, Schaefer M, Archer J, Seubert A, Otten GR, Beard CW, Dey AK, Lilja A, Valiante NM, Mason PW, Mandl CW, Barnett SW, Dormitzer PR, Ulmer JB, Singh M, O'Hagan DT, Geall AJ.

Mol Ther. 2014 Dec;22(12):2118-29. doi: 10.1038/mt.2014.133. Epub 2014 Jul 16.

2.

Potent immune responses in rhesus macaques induced by nonviral delivery of a self-amplifying RNA vaccine expressing HIV type 1 envelope with a cationic nanoemulsion.

Bogers WM, Oostermeijer H, Mooij P, Koopman G, Verschoor EJ, Davis D, Ulmer JB, Brito LA, Cu Y, Banerjee K, Otten GR, Burke B, Dey A, Heeney JL, Shen X, Tomaras GD, Labranche C, Montefiori DC, Liao HX, Haynes B, Geall AJ, Barnett SW.

J Infect Dis. 2015 Mar 15;211(6):947-55. doi: 10.1093/infdis/jiu522. Epub 2014 Sep 18.

3.

Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines.

Deering RP, Kommareddy S, Ulmer JB, Brito LA, Geall AJ.

Expert Opin Drug Deliv. 2014 Jun;11(6):885-99. doi: 10.1517/17425247.2014.901308. Epub 2014 Mar 26. Review.

PMID:
24665982
4.

Nonviral delivery of self-amplifying RNA vaccines.

Geall AJ, Verma A, Otten GR, Shaw CA, Hekele A, Banerjee K, Cu Y, Beard CW, Brito LA, Krucker T, O'Hagan DT, Singh M, Mason PW, Valiante NM, Dormitzer PR, Barnett SW, Rappuoli R, Ulmer JB, Mandl CW.

Proc Natl Acad Sci U S A. 2012 Sep 4;109(36):14604-9. doi: 10.1073/pnas.1209367109. Epub 2012 Aug 20.

5.

Induction of Broad-Based Immunity and Protective Efficacy by Self-amplifying mRNA Vaccines Encoding Influenza Virus Hemagglutinin.

Brazzoli M, Magini D, Bonci A, Buccato S, Giovani C, Kratzer R, Zurli V, Mangiavacchi S, Casini D, Brito LM, De Gregorio E, Mason PW, Ulmer JB, Geall AJ, Bertholet S.

J Virol. 2015 Oct 14;90(1):332-44. doi: 10.1128/JVI.01786-15.

6.

Self-amplifying mRNA vaccines.

Brito LA, Kommareddy S, Maione D, Uematsu Y, Giovani C, Berlanda Scorza F, Otten GR, Yu D, Mandl CW, Mason PW, Dormitzer PR, Ulmer JB, Geall AJ.

Adv Genet. 2015;89:179-233. doi: 10.1016/bs.adgen.2014.10.005. Epub 2014 Dec 4.

PMID:
25620012
7.

A cationic sub-micron emulsion (MF59/DOTAP) is an effective delivery system for DNA vaccines.

Ott G, Singh M, Kazzaz J, Briones M, Soenawan E, Ugozzoli M, O'Hagan DT.

J Control Release. 2002 Feb 19;79(1-3):1-5.

PMID:
11853914
8.

Cationic microparticles are a potent delivery system for a HCV DNA vaccine.

O'Hagan DT, Singh M, Dong C, Ugozzoli M, Berger K, Glazer E, Selby M, Wininger M, Ng P, Crawford K, Paliard X, Coates S, Houghton M.

Vaccine. 2004 Dec 16;23(5):672-80.

PMID:
15542189
9.

Enhanced Delivery and Potency of Self-Amplifying mRNA Vaccines by Electroporation in Situ.

Cu Y, Broderick KE, Banerjee K, Hickman J, Otten G, Barnett S, Kichaev G, Sardesai NY, Ulmer JB, Geall A.

Vaccines (Basel). 2013 Aug 22;1(3):367-83. doi: 10.3390/vaccines1030367.

10.

Route and method of delivery of DNA vaccine influence immune responses in mice and non-human primates.

McCluskie MJ, Brazolot Millan CL, Gramzinski RA, Robinson HL, Santoro JC, Fuller JT, Widera G, Haynes JR, Purcell RH, Davis HL.

Mol Med. 1999 May;5(5):287-300.

11.

Intranasal immunization with W 80 5EC adjuvanted recombinant RSV rF-ptn enhances clearance of respiratory syncytial virus in a mouse model.

Passmore C, Makidon PE, O'Konek JJ, Zahn JA, Pannu J, Hamouda T, Bitko V, Myc A, Lukacs NW, Fattom A, Baker JR Jr.

Hum Vaccin Immunother. 2014;10(3):615-22. Epub 2013 Dec 10.

12.

mRNA vaccine delivery using lipid nanoparticles.

Reichmuth AM, Oberli MA, Jeklenec A, Langer R, Blankschtein D.

Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Review.

13.

CD8 T-cell priming upon mRNA vaccination is restricted to bone-marrow-derived antigen-presenting cells and may involve antigen transfer from myocytes.

Lazzaro S, Giovani C, Mangiavacchi S, Magini D, Maione D, Baudner B, Geall AJ, De Gregorio E, D'Oro U, Buonsanti C.

Immunology. 2015 Oct;146(2):312-26. doi: 10.1111/imm.12505. Epub 2015 Aug 28.

14.

Induction of HIV-1 gag specific immune responses by cationic micelles mediated delivery of gag mRNA.

Zhao M, Li M, Zhang Z, Gong T, Sun X.

Drug Deliv. 2016 Sep;23(7):2596-2607. Epub 2015 May 29.

PMID:
26024387
15.

Cationic influenza virosomes as an adjuvanted delivery system for CTL induction by DNA vaccination.

Jamali A, Holtrop M, de Haan A, Hashemi H, Shenagari M, Memarnejadian A, Roohvand F, Sabahi F, Kheiri MT, Huckriede A.

Immunol Lett. 2012 Nov-Dec;148(1):77-82. doi: 10.1016/j.imlet.2012.08.006. Epub 2012 Sep 7.

PMID:
22981929
17.

Messenger RNA vaccine based on recombinant MS2 virus-like particles against prostate cancer.

Li J, Sun Y, Jia T, Zhang R, Zhang K, Wang L.

Int J Cancer. 2014 Apr 1;134(7):1683-94. doi: 10.1002/ijc.28482. Epub 2013 Oct 8. Erratum in: Int J Cancer. 2014 Oct 1;135(7):E5.

18.

In vivo electroporation of minicircle DNA as a novel method of vaccine delivery to enhance HIV-1-specific immune responses.

Wang Q, Jiang W, Chen Y, Liu P, Sheng C, Chen S, Zhang H, Pan C, Gao S, Huang W.

J Virol. 2014 Feb;88(4):1924-34. doi: 10.1128/JVI.02757-13. Epub 2013 Nov 27.

19.

Plasmid DNA and viral vector-based vaccines for the treatment of cancer.

Anderson RJ, Schneider J.

Vaccine. 2007 Sep 27;25 Suppl 2:B24-34. Epub 2007 Jun 6. Review.

PMID:
17698262
20.

A DNA vaccine for venezuelan equine encephalitis virus delivered by intramuscular electroporation elicits high levels of neutralizing antibodies in multiple animal models and provides protective immunity to mice and nonhuman primates.

Dupuy LC, Richards MJ, Ellefsen B, Chau L, Luxembourg A, Hannaman D, Livingston BD, Schmaljohn CS.

Clin Vaccine Immunol. 2011 May;18(5):707-16. doi: 10.1128/CVI.00030-11. Epub 2011 Mar 30.

Supplemental Content

Support Center